A carregar...
DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION
The DNA alkylating agent temozolomide (TMZ) is active against the subset of glioblastomas (GBMs) in which the O6-methylguanine DNA methyltransferase (MGMT) gene is silenced by promoter methylation. However, despite their initial sensitivity, virtually all MGMT-methylated tumors acquire drug resistan...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216424/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.313 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|